HealthPrize Technologies, the leading cloud-based patient engagement and adherence platform for life science companies, announced today the appointment of John Monahan to the newly-created role of President.
Leica Biosystems, the leader in cancer diagnostics from biopsy to diagnosis, today announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system for breast tissue biopsies, which average 1.6 million a year in the United States alone.
Nanion announced today that Charles River Laboratories has purchased two SyncroPatch 384PE high-throughput patch clamp instruments. This purchase reflects an investment in screening technologies and assay development, while accommodating the rising demand in contract service for globally shared clients.
RTI Surgical, Inc., a global surgical implant company, announced its TETRAfuse® 3D Technology won a 2018 Spine Technology Award from Orthopedics This Week, a widely read publication in the orthopedics industry.
Equipped with knowledge and backed by rich industry experience, British Biologicals, an award-winning global nutraceutical company, has announced Bharath Reddy, Director of International Business Development and Operations, will lead the company’s expansion into the United States for an end-to-end solution for the nutritional supplement industry.
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the appointment of Joseph Scalia to its executive leadership team as Vice President of Commercial Sales and Marketing. In this role, he is responsible for the company's U.S. commercial operations.
SOPHiA GENETICS, leader in Data-Driven Medicine, today announced from the Personalized Medicine World Congress (PMWC) at Duke University that the company has opened operations in Boston to meet the burgeoning demand across the United States.
Tilray Inc., a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada, was successfully imported into the United Kingdom, to supply a pediatric patient in need.
EnteroBiotix, a leading clinical stage microbiome therapeutics company, has been granted a manufacturers ‘specials’ license from the Medicines and Healthcare Products Regulatory Agency (MHRA) to further its therapeutic and product pipeline.